Physician profile
Daniel J Harmon
NPI 1790948388
$21,291.24
in general payments reported to CMS, 2019-2025
19 companies · $6,189 in 2025
The $6,189 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,080 · 2020: $1,851 · 2021: $2,828 · 2022: $898 · 2023: $6,230 · 2024: $2,215 · 2025: $6,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,266 · Consulting Fee: $4,951 · Food and Beverage: $3,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,266.39 |
| Consulting Fee | $4,950.80 |
| Food and Beverage | $3,416.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,074.53 | 2023 | Real Intelligence, Ri Hip Navigation, Journey II |
| Depuy Synthes Products, INC. | $5,011.39 | 2025 | Kincise |
| Stryker Corporation | $4,374.65 | 2019-2025 | Mako, Triathlon, Insignia |
| Medical Device Business Services, INC. | $3,166.60 | 2021-2024 | Kincise |
| Zimmer Biomet Holdings, INC. | $1,280.81 | 2019-2025 | Rosa, Persona, Mymobility Platform |
| Integra Lifesciences Corporation | $840.44 | 2019-2021 | |
| Depuy Synthes Sales INC. | $607.54 | 2019-2025 | Va-Lcp, Na |
| Baudax Bio INC. | $250.58 | 2021 | |
| Bone Support INC. | $147.36 | 2025 | Ceramentbone Void Filler, Cerament G |
| Aroa Biosurgery Incorporated | $109.85 | 2022 | |
| Kerecis Limited | $88.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Rock Medical Orthopedics, INC. | $82.11 | 2020 | |
| Ortho Development Corporation | $67.82 | 2019 | |
| Orthalign INC | $56.69 | 2020 | |
| Innovation Technologies INC | $38.73 | 2024 | Irrisept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $33.74 | 2019 | |
| Si-Bone, INC. | $25.96 | 2022 | |
| Solventum Corporation | $21.15 | 2025 | V.A.C. Veraflo, Prevena |
| Axonics, INC. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.